Cell Penetrating Peptide Global Market Report 2025
상품코드:1825657
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세포 투과성 펩티드 시장 규모는 향후 몇 년 동안 급성장할 것으로 예측됩니다. 2029년에는 CAGR 13.7%로 35억 7,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 희귀질환에 대한 새로운 펩타이드 기반 치료제 개발, 신흥국 시장의 헬스케어 인프라에 대한 투자 확대, 펩타이드 기반 백신 및 면역 요법에 대한 수요 증가, 펩타이드 의약품 승인 절차 간소화를 위한 규제 당국의 노력, 지속 가능하고 생분해 가능한 펩타이드 전달 시스템으로의 전환에 기인합니다. 펩타이드 전달 시스템으로의 전환 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 특정 치료 용도를 위한 세포 투과성 펩티드의 맞춤화, 세포 내 전달 도구로서의 세포 투과성 펩티드의 탐구, 펩타이드 설계에 인공지능과 머신러닝의 통합, 세포 투과성 펩티드의 통합, 새로운 전달 경로의 채택 등이 있습니다.
향후 5년간 13.7%의 성장률 전망은 지난번 예측보다 1.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가들 간의 관세의 영향에 기인합니다. 관세 장벽은 중국이나 이탈리아에서 조달하는 세포 투과성 펩티드(CPP) 결합 시약 및 트랜스펙션 시스템의 비용을 상승시키고, 중요한 실험에서 세포 내 전달 효율을 40-60% 감소시킴으로써 미국의 약물 전달 기술 혁신을 저해할 것으로 예측됩니다. 또한, 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
세포침투 펩타이드 시장의 성장은 건강 연구 및 개발(R&&D)에 대한 투자 증가에 의해 주도될 것으로 예측됩니다. 건강 R&&D는 과학적 이해를 증진하고 더 나은 의료 결과를 위한 혁신적인 솔루션을 개발하기 위한 체계적인 탐구와 실험을 포함합니다. 이러한 R&D 투자 증가는 의료 수요, 기술 발전, 세계 보건 우선순위, 투자 인센티브, 경제적 기회 등에 의해 촉진될 것입니다. 세포 투과성 펩티드는 특히 약물 전달, 유전자 치료, 백신 개발, 분자 이미징, 세포 연구 등 건강 R&&D의 추진에 중요한 역할을 하고 있습니다. 예를 들어,2023년 12월 미국 주정부 기관은 2022 회계연도에 11억 달러의 보건 연구개발비를 배정해 2021 회계연도의 10억 7,000만 달러에서 2.2% 증가하였습니다. 따라서, 연구 개발 활동 증가는 세포 침투 펩타이드 시장의 성장을 가속하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 세포 투과성 펩티드 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 세포 투과성 펩티드 시장 : 성장률 분석
세계의 세포 투과성 펩티드 시장 실적 : 규모와 성장, 2019-2024
세계의 세포 투과성 펩티드 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 세포 투과성 펩티드 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 세포 투과성 펩티드 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
합성 세포 투과 펩티드
단백질 유래 세포 투과 펩티드
키메라 세포 투과 펩티드
세계의 세포 투과성 펩티드 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
약물전달
유전자 전달
진단
분자 이미징
기타 용도
세계의 세포 투과성 펩티드 시장 : 최종 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제약 및 바이오테크놀러지 기업
임상시험 수탁기관(CRO)
병원 및 진료소
기타 최종사용자
세계의 세포 투과성 펩티드 시장 : 세분화 합성 세포 투과성 펩티드(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
선형 합성 CPP
분기 합성 CPP
펩티드 접합체
지질 수식 합성 CPP
세계의 세포 투과성 펩티드 시장 : 세분화 단백질 유래 세포 투과성 펩티드(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
Tat Peptides (From HIV-1 TAT)
Antennapedia Peptides
Homeodomain Peptides
기타 천연 유래 CPP
세계의 세포 투과성 펩티드 시장 : 키메라 세포 투과 펩티드(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
융합 펩티드
하이브리드 펩티드
제7장 지역별/국가별 분석
세계의 세포 투과성 펩티드 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 세포 투과성 펩티드 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
세포 투과성 펩티드 시장 : 경쟁 구도
세포 투과성 펩티드 시장 : 기업 개요
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Novo Nordisk A/S : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Corden Pharma GmbH : 개요, 제품 및 서비스, 전략 및 재무 분석
Sarepta Therapeutics Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
GenScript Biotech Corporation
Bachem Holding AG
R&D Systems Inc.
PolyPeptide Laboratories AB
PeptiDream Inc.
Revance Therapeutics Inc.
CPC Scientific Inc.
Tocris Bioscience
Bio-Synthesis Inc.
AnaSpec Inc.
Avidity Biosciences Inc.
Iris Biotech GmbH
PEPperPRINT GmbH
Chemos GmbH & Co. KG
Creative Peptides GmbH
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
세포 투과성 펩티드 시장(2029년) : 새로운 기회를 제공하는 국가
세포 투과성 펩티드 시장(2029년) : 새로운 기회를 제공하는 부문
세포 투과성 펩티드 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Cell-penetrating peptides (CPPs), also referred to as protein transduction domains (PTDs) or membrane translocation peptides, are short peptides typically comprising 5 to 30 amino acids. They possess the capability to traverse cell membranes and facilitate the intracellular delivery of diverse cargo molecules, including proteins, nucleic acids, and small molecules. These peptides enable the transport of various cargoes across biological barriers such as the plasma membrane, endosomal membranes, and nuclear envelope, without causing significant cellular damage.
The primary types of cell-penetrating peptides include synthetic cell-penetrating peptides, protein-derived cell-penetrating peptides, and chimeric cell-penetrating peptides. Synthetic cell-penetrating peptides are artificially created in laboratory settings, often through chemical synthesis methods. These peptides find applications in drug delivery, gene delivery, diagnostics, molecular imaging, and other pharmaceutical and biotechnology-related applications, catering to entities such as pharmaceutical and biotechnology companies, contract research organizations (CROs), hospitals and clinics, among others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The cell-penetrating peptide market research report is one of a series of new reports from The Business Research Company that provides cell-penetrating peptide market statistics, including cell-penetrating peptide industry global market size, regional shares, competitors with cell-penetrating peptide market share, detailed cell-penetrating peptide market segments, market trends, and opportunities, and any further data you may need to thrive in the cell-penetrating peptide industry. This cell-penetrating peptide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cell penetrating peptide market size has grown rapidly in recent years. It will grow from $1.87 billion in 2024 to $2.14 billion in 2025 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to increased understanding of cellular uptake mechanisms, growth in demand for targeted drug delivery systems, rising prevalence of chronic diseases, emergence of personalized medicine approaches, and expansion of pharmaceutical research and development.
The cell penetrating peptide market size is expected to see rapid growth in the next few years. It will grow to $3.57 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to development of novel peptide-based therapeutics for rare diseases, growing investment in healthcare infrastructure in emerging markets, rising demand for peptide-based vaccines and immunotherapies, regulatory initiatives to streamline approval processes for peptide drugs, and shift towards sustainable and biodegradable peptide delivery systems. Major trends in the forecast period include customization of cell penetration peptides for specific therapeutic applications, exploration of cell-penetrating peptides as tools for intracellular delivery, integration of artificial intelligence and machine learning in peptide design, integration of cell-penetrating peptides, and adoption of novel delivery routes.
The forecast of 13.7% growth over the next five years reflects a modest reduction of 1.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. drug delivery innovation by increasing the cost of Cell-Penetrating Peptides(CPP)-conjugated reagents and transfection systems sourced from China and Italy, thereby reducing intracellular delivery efficiency by 40-60% in critical experiments. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growth of the cell penetration peptide market is expected to be driven by increasing investment in health research and development (R&D). Health R&D involves systematic exploration and experimentation to advance scientific understanding and develop innovative solutions for better healthcare outcomes. This increase in R&D investment is fueled by healthcare needs, technological advancements, global health priorities, investment incentives, and economic opportunities. Cell penetration peptides play a crucial role in advancing health R&D, particularly in drug delivery, gene therapy, vaccine development, molecular imaging, and cellular research. For example, in December 2023, state government agencies in the US allocated $1.10 billion towards health R&D in fiscal year 2022, marking a 2.2% increase from fiscal year 2021's $1.07 billion expenditure. Hence, the rise in R&D activities is propelling the growth of the cell penetration peptide market.
Key players in the cell penetration peptide market are focusing on innovative platforms such as peptide drug discovery platforms to gain a competitive advantage. These platforms streamline the identification, design, optimization, and evaluation of CPP-based therapeutics. For instance, in May 2023, Fujitsu Limited introduced the Biodrug Design Accelerator, a platform aiding peptide drug discovery scientists in pharmaceutical firms by expediting and enhancing the efficiency of peptide drug development, particularly through the 'design, make, test, analyze' (DMTA) cycles. It facilitates communication among scientists regarding synthesis and testing, compatible with HELM, a method for describing complex biomolecules.
In December 2023, Invaio Sciences, a US company specializing in human health and digital innovation solutions, acquired Peptyde Bio for an undisclosed sum. This acquisition equips Invaio with a strong platform and intellectual property portfolio, enabling the company to expedite the development and discovery of biologically active peptides. Peptyde Bio, also based in the US, focuses on discovering, designing, and characterizing novel cell-penetrating peptides.
North America was the largest region in the cell penetrating peptide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell penetrating peptide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cell penetrating peptide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cell-penetrating peptide market consists of revenues earned by entities by providing services such as custom synthesis services, peptide conjugation services, preclinical and clinical testing services, and delivery system development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell penetrating peptide market also includes sales of automated peptide synthesizers, mass spectrometers, fluorescence microscopes, and flow cytometers which are used in providing cell penetrating peptide services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Penetrating Peptide Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cell penetrating peptide market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cell penetrating peptide ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell penetrating peptide market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Cell Penetrating Peptide Market Trends And Strategies
4. Cell Penetrating Peptide Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Cell Penetrating Peptide Growth Analysis And Strategic Analysis Framework
5.1. Global Cell Penetrating Peptide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cell Penetrating Peptide Market Growth Rate Analysis
5.4. Global Cell Penetrating Peptide Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cell Penetrating Peptide Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cell Penetrating Peptide Total Addressable Market (TAM)
6. Cell Penetrating Peptide Market Segmentation
6.1. Global Cell Penetrating Peptide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Synthetic Cell Penetrating Peptides
Protein-Derived Cell Penetrating Peptides
Chimeric Cell Penetrating Peptides
6.2. Global Cell Penetrating Peptide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Delivery
Gene Delivery
Diagnostics
Molecular Imaging
Other Applications
6.3. Global Cell Penetrating Peptide Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Contract Research Organization (CROs)
Hospitals And Clinics
Others End Users
6.4. Global Cell Penetrating Peptide Market, Sub-Segmentation Of Synthetic Cell Penetrating Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Linear Synthetic CPPs
Branched Synthetic CPPs
Peptide Conjugates
Lipid-Modified Synthetic CPPs
6.5. Global Cell Penetrating Peptide Market, Sub-Segmentation Of Protein-Derived Cell Penetrating Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tat Peptides (From HIV-1 TAT)
Antennapedia Peptides
Homeodomain Peptides
Other Naturally Derived CPPs
6.6. Global Cell Penetrating Peptide Market, Sub-Segmentation Of Chimeric Cell Penetrating Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fusion Peptides
Hybrid Peptides
7. Cell Penetrating Peptide Market Regional And Country Analysis
7.1. Global Cell Penetrating Peptide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cell Penetrating Peptide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
